Session » Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster I

Date: Sunday, October 21, 2018

Time: 9:00AM-11:00AM

Meeting: 2018 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 89

Anti-Nuclear Antibodies (ANA) and Air Pollution: Ultrafine Particles and Ozone

9:00AM-11:00AM: Abstract Number: 107

Apolipoprotein L1 Risk Variants, Renal Histopathology, and Prognosis in African American SLE Nephritis Patients: A Cohort Study

9:00AM-11:00AM: Abstract Number: 93

Biomarkers Associating Endothelial Function in Systemic Lupus Erythematous

9:00AM-11:00AM: Abstract Number: 94

Circulating Soluble MICA Is Associated to Lupus Nephritis and to a TLR/IFN-I Signature in T Cells in a Cohort of Adult SLE Patients

9:00AM-11:00AM: Abstract Number: 99

DC-Hil+ Myeloid-Derived Suppressor Cells Are Elevated in the Peripheral Blood and Lesional Skin of Cutaneous Lupus Patients

9:00AM-11:00AM: Abstract Number: 90

Deoxyribonuclease 1-like-3 Digests Self-DNA from Dead Cells and Prevents Autoimmunity

9:00AM-11:00AM: Abstract Number: 97

Enhanced IFN-α Production By Plasmacytoid Dendritic Cells Is Associated with Increased Toll-like Receptor 7 Retention in the Lysosomes and Exosure to Type I IFN in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 102

Estrogen Controls the Expression of Serine Arginine-Rich Splicing Factor 1 (SRSF1) in Human T Lymphocytes Via Transcriptional and Post-Transcriptional Mechanisms

9:00AM-11:00AM: Abstract Number: 95

Expression of SLAMF6 and Its Functional Significance in Podocytes of Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 100

Glycosphingolipids and Proteins in Urine Exosomes: Potential Biomarkers of Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 106

Highly Elevated Levels of Anti-Mitochondrial Antibodies in Systemic Lupus Erythematosus and Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 104

Identification of a Gut Pathobiont Immunostimulatory Lipoglycan Antigen Linked to Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 103

Identification of IL-17+ and IL-10+ TCRαβ+ CD4- CD8- double Negative (DN) T Cell Subsets in Lupus-Prone Mice and Patients with SLE and Their Significance in Predicting Renal Involvement

9:00AM-11:00AM: Abstract Number: 105

Immunologic Properties of Cutaneous Lupus Erythematosus (CLE) Patients Refractory to Antimalarials Compared to Patients That Respond to Antimalarials

9:00AM-11:00AM: Abstract Number: 92

Lupus Nephritis Serum Induces Neutrophil Chemotaxis Towards Glomerular Endothelial Cells in Vitro

9:00AM-11:00AM: Abstract Number: 98

Presence of Apoptotic Microparticle Containing Immune Complexes in Asymptomatic ANA+ Individuals Despite the Absence of Inflammation

9:00AM-11:00AM: Abstract Number: 101

Regulation of Monocyte Function By Epstein Barr Virus Interleukin-10 (vIL10) in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 108

Sex-Specific Expression of CXorf21 Provide Molecular Explanation for the Fundamental Difference in Male and Female Immune Response: An Explanation for Female-Bias SLE Pathogenesis

9:00AM-11:00AM: Abstract Number: 110

Single-Cell RNA-Seq Analysis of ANA+ Healthy and SLE Patients Show Variations in Activated Stress Response and Regulatory Pathways

9:00AM-11:00AM: Abstract Number: 96

The Liver X Receptor Modulates Inflammatory Cytokines Based on Lxrα Polymorphism in Monocyte-Derived Macrophages and Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 91

Type I IFN Production Is Induced By Non-Haematopoietic Tissue Cells but Not Plasmacytoid Dendritic Cells in Preclinical Autoimmunity and SLE

9:00AM-11:00AM: Abstract Number: 109

Unique miRNA Signatures Detected in Extracellular Vesicles from Patients with Systemic Lupus Erythematous

« View all sessions from this meeting